Registry and Monitoring of ImmuNe-mediated Inflammatory Diseases

Registry and Monitoring of ImmuNe-mediated Inflammatory Diseases (IMIDs) REMIND Study

Formation of a registry of IMID patients to assess the evolution of resistance to conventional and target therapies. This aim is achieved by evaluating the achievement of PASI 50 and PASI 75 scores at week 16 from the start of treatment.

Inclusion Criteria:

• Patients with a diagnosis of IMID.
• Patients of any age, including minors.
• Patients treated with approved medications for the condition in question and/or phototherapy.
• Patients who agree to sign informed consent.

Exclusion Criteria:

• Patients without a diagnosis of IMID.
• Patients who do not consent to sign informed consent.